0182.KLSE LKL International Bhd
- Market cap
- MYR 11.6M
- P/E
- -
- P/B
- 0.12x
- ROE
- -25.1%
- Dividend yield
- -
- Fundamental score
- 1.6/5
Ratios use the latest price and the fiscal year ending Apr 2026.
Is 0182.KLSE undervalued?
Graham numberThe Graham number of LKL International Bhd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LKL International Bhd fundamental analysis
7 of 21 checks passedROE 0/2
Low return on equity (-25.1%), below 10%.
ROA 0/1
Return on assets (-16.5%) is below the industry median (1.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (35.9%) is above the industry median (-0.5%).
Revenue Growth 0/2
Revenue shrank 18.0% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (17.4%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 2/2
Cash covers 3.3 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.1x) is below the industry median (0.6x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About LKL International Bhd
LKL International Berhad, an investment holding company, engages in the manufacturing of medical and healthcare beds, medical peripherals, and accessories in Malaysia, Africa, Europe, the Middle East, and the rest of Asia. It operates through three segments: Manufacturing, Trading, and Retail. The company offers A&E patient transport trolley, cart and trolley, curtain track, delivery bed, examination table, instrument trolley, manual crank bed, medical chair, nursery equipme…
Full company profileLKL International Bhd financial statements
LKL International Bhd annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 33.9M | 29.7M | 37.2M | 55.0M | 75.5M | 85.4M | 102M | 44.6M | 47.6M | 56.5M |
| Gross Profit | 16.9M | 10.9M | 10.6M | 19.8M | 17.2M | 13.4M | 14.9M | 16.0M | 11.0M | 10.6M |
| Operating Income | 6.52M | -771K | -2.50M | 6.01M | -51.5M | -2.38M | -21.0M | -2.21M | -42.1M | -22.3M |
| EBITDA | 7.86M | 1.01M | -517K | 8.33M | - | 3.64M | - | 3.26M | -34.6M | -17.8M |
| Net Income | 4.48M | -1.10M | -2.50M | 4.30M | -51.6M | 1.14M | -20.4M | -6.98M | -41.3M | -26.5M |
| EPS | 0.08 | -0.02 | -0.04 | 0.08 | -0.51 | 0.01 | -0.16 | -0.02 | -0.11 | -0.07 |
| Balance Sheet | ||||||||||
| Total Assets | 72.3M | 72.4M | 70.0M | 79.1M | 154M | 167M | 150M | 215M | 192M | 161M |
| Total Liabilities | 12.5M | 13.7M | 13.8M | 18.7M | 18.3M | 16.2M | 20.4M | 43.3M | 61.2M | 56.2M |
| Shareholders' Equity | 59.8M | 58.7M | 56.2M | 60.5M | 136M | 152M | 130M | 172M | 130M | 105M |
| Cash & Short-term Investments | 23.7M | 14.3M | 12.4M | 6.18M | 80.7M | 8.30M | 26.7M | 36.6M | 25.7M | 14.8M |
| Total Debt | 7.84M | 7.35M | 5.89M | 8.13M | 6.60M | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 2.53M | -2.35M | 865K | -6.98M | -21.3M | -12.9M | -6.08M | -16.1M | -17.2M | -1.31M |
| Capital Expenditure | 6.89M | 6.42M | 541K | 1.58M | 10.9M | 26.4M | 20.8M | 26.0M | 18.3M | 3.18M |
| Free Cash Flow | -4.37M | -8.77M | 324K | -8.75M | 3.98M | -39.3M | - | -42.1M | -35.5M | -4.49M |
| Ratios | ||||||||||
| ROE | 7.5% | -1.9% | -4.4% | 7.1% | -38.0% | 0.7% | -15.7% | -4.1% | -31.7% | -25.1% |
| ROA | 6.2% | -1.5% | -3.6% | 5.4% | -33.5% | 0.7% | -13.6% | -3.2% | -21.6% | -16.5% |
| Net Profit Margin | 13.2% | -3.7% | -6.7% | 7.8% | -68.4% | 1.3% | -19.9% | -15.7% | -86.8% | -46.9% |
| Debt to Equity | 0.13x | 0.13x | 0.10x | 0.13x | 0.05x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
LKL International Bhd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Apr 3, 2017
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | MYR 1.50M | 0.03 | 33.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Oct 13, 2022.
Who owns LKL International Bhd
- Insiders 46.81%
- Institutions 0.28%
- Public & others 52.92%
- Shares outstanding 388M
- Free float 207M
LKL International Bhd company profile
- Company name
- LKL International Bhd
- Ticker
- 0182.KLSE
- ISIN
- MYQ0182OO004
- Exchange
- Kuala Lumpur Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 196
- Fiscal year end
- April
- Address
- Wisma LKL, Seri Kembangan, Malaysia, 43300
- Phone
- 60 3 8948 2990
- Website
- lklbeds.com
About LKL International Bhd
LKL International Berhad, an investment holding company, engages in the manufacturing of medical and healthcare beds, medical peripherals, and accessories in Malaysia, Africa, Europe, the Middle East, and the rest of Asia. It operates through three segments: Manufacturing, Trading, and Retail. The company offers A&E patient transport trolley, cart and trolley, curtain track, delivery bed, examination table, instrument trolley, manual crank bed, medical chair, nursery equipment, and patient room furniture, as well as hospital electrical bed, hospital hydraulic bed, and hospital ICU and CCU electrical bed; and miscellaneous hospital equipment, such as x-ray viewer, concealment collection table, and surgical bowl stand. It also provides a range of drugs, chemicals, alkalis, cosmetics, personal care, health food, medical device, manure antibodies, and pharmaceutical medicine through its retail pharmacy business; and management and advisory services. In addition, the company is involved in the trading of hospital furniture, laboratory furniture, medical equipment, utensils, and accessories; and property development and general trading. Its products are used in hospitals, medical centers, and other healthcare-related facilities, including clinics and specialist institutions. LKL International Berhad was founded in 1993 and is headquartered in Seri Kembangan, Malaysia.
LKL International Bhd management
6- Mr. Lian Seng TiMD & Director · born 1968
- Mr. Pak Hong LimExecutive Director · born 1986
- Ms. Pei Fern WongChief Financial Officer · born 1977
- Mr. Kah Earng LeeSales Director · born 1970
- Ms. Sor Hua TeaCompany Secretary · born 1971
- Mui Yee ThienJoint Secretary